Ascendis Pharma, Inc.

147 articles with Ascendis Pharma, Inc.

• Ascendis Announces Year-End 2016 Financial Results Conference Call On March 22

  3/10/2017

• Ascendis Announces Publication Of Comprehensive Results From Randomized, Active-Controlled Phase 2 Trial Of Once-Weekly Transcon Growth Hormone In Pediatric Patients

  2/17/2017

• Ascendis Reports Third Quarter 2016 Financial Results

  12/1/2016

• Ascendis To Report Third Quarter 2016 Financial Results And Host Conference Call On November 30

  11/17/2016

• Ascendis Eyes $112 Million IPO to Fund the Development of Growth Hormone Drug

  10/19/2016

• Ascendis Pharma A/S Announces Proposed Public Offering Of ADSs

  10/18/2016

• Ascendis Pharma A/S Announces Webcast Of R&D Update

  9/23/2016

• Ascendis Pharma A/S Announces Multiple Transcon Growth Hormone Presentations At The European Society Of Paediatric Endocrinology Annual Meeting

  9/9/2016

• Ascendis Pharma A/S Reports Second Quarter 2016 Financial Results And Provides Business Update

  9/1/2016

• Ascendis Pharma A/S To Report Second Quarter 2016 Financial Results And Host Conference Call On August 31

  8/19/2016

• Ascendis Pharma A/S Announces R&D Update To Review Expanded Pipeline And Long-Term Strategic Outlook

  8/16/2016

• Ascendis Pharma A/S Initiates Phase 3 Registration Trial For TransCon Growth Hormone In Children With Growth Hormone Deficiency

  8/11/2016

• Ascendis Pharma A/S Appoints Scott T. Smith As Chief Financial Officer

  8/8/2016

• Ascendis Pharma A/S Reports First Quarter 2016 Financial Results

  5/20/2016

• Ascendis Pharma A/S To Present At The UBS Global Healthcare Conference On May 23, 2016

  5/18/2016

• Ascendis Pharma A/S To Present At The Bank of America Merrill Lynch 2016 Healthcare Conference On May 11, 2016

  5/6/2016

• Ascendis Pharma A/S Reports Full Year 2015 Financial Results

  4/15/2016

• Ascendis Pharma A/S Announces TransCon Growth Hormone Oral And Poster Presentations At ENDO 2016

  4/4/2016

• Ascendis Pharma A/S Appoints Jonathan A. Leff, M.D. As Chief Medical Officer

  2/25/2016

• Ascendis Pharma A/S To Present At The Leerink Partners Global Healthcare Conference

  2/4/2016